Fairey William 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Fairey William
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-29+5,703→ 5,703 total - Exercise/Conversion
Restricted Stock Units
2025-05-29−5,703→ 0 total→ Common Stock (5,703 underlying) - Award
Deferred Stock Units
2025-05-29+3,977→ 3,977 total→ Common Stock (3,977 underlying) - Award
Stock Option (right to buy)
2025-05-29+6,268→ 6,268 totalExercise: $44.00Exp: 2035-05-28→ Common Stock (6,268 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]The restricted stock unit vests on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting.
- [F3]The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting.
- [F4]Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer.